SNN

$31.94-0.40 (-1.24%)

Market ClosedAs of Mar 20, 8:00 PM UTC

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$31.94
Potential Downside
9.3%
Whystock Fair Value$28.97
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Devices

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$13.56B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
22.34
Beta
Defensive asset. Lower volatility than the S&P 500.
0.68
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
11.29%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.40

Recent News

Financial Times
Mar 21, 2026

How the FTSE grew comfortable with bumper pay for bosses

British boards are handing chief executives bumper pay awards in a sign that investors are buying the argument that they should approve large...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Barrons.com
Mar 20, 2026

BlackLine, Smith & Nephew, and More Stocks See Action From Activist Investors

13D FILINGS These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 11, 2026

SNN Launches ALLEVYN COMPLETE CARE Dressing for Wound Management

Smith + Nephew launches ALLEVYN COMPLETE CARE foam dressing for wound management, expanding its Advanced Wound Management portfolio.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MT Newswires
Mar 5, 2026

European Equities Traded in the US as American Depositary Receipts Slide in Thursday Trading

European equities traded in the US as American depositary receipts were sliding late Thursday mornin

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
MT Newswires
Mar 4, 2026

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

European equities traded in the US as American depositary receipts were tracking higher late Wednesd

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.